• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

    7/24/24 5:27:11 AM ET
    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ALLR alert in real time by email

    Shares of Enphase Energy, Inc. (NASDAQ:ENPH) rose sharply in today's pre-market trading after the company reported second-quarter financial results.

    Enphase Energy reported second-quarter revenue of $303.46 million, missing the consensus estimate of $309.67 million, according to Benzinga Pro. The company reported adjusted earnings of 43 cents per share, missing analyst estimates of 48 cents per share.

    Enphase Energy shares gained 6.2% to $110.10 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) rose 146.2% to $3.20 in pre-market trading after falling over 22% on Tuesday.
    • NuZee, Inc.  (NASDAQ:NUZE) gained 87.4% to $1.93 in pre-market trading.
    • Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares climbed 65.4% to $24.74 in pre-market trading after jumping 344% on Tuesday.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 41.1% to $0.2350 in pre-market trading. Allarity Therapeutics revealed on Monday it received a "Wells Notice" from the U.S. Securities and Exchange Commission (SEC).
    • NewGenIvf Group Limited (NASDAQ:NIVF) shares gained 30.1% to $1.12 in pre-market trading after the company announced steady progress in its due diligence efforts in its proposed reverse merger with COVIRIX Medical and anticipates completion by the end of August 2024.
    • Perfect Moment Ltd.  (NASDAQ:PMNT) gained 19% to $2.20 in pre-market trading after gaining around 9% on Tuesday.
    • ENGlobal Corporation (NASDAQ:ENG) shares gained 15% to $2.00 in pre-market trading.
    • 1847 Holdings LLC (NYSE:EFSH) shares gained 14.4% to $2.30 in pre-market trading after falling over 17% on Tuesday. 1847 Holdings recently announced a 1-for-13 reverse split.
    • Seagate Technology Holdings plc (NASDAQ:STX) shares surged 5.3% to $110.90 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.

    Losers

    • Azitra, Inc. (NYSE:AZTR) shares fell 74.7% to $1.26 in pre-market trading. Azitra announced the pricing of $10.0 million public offering.
    • Conn’s, Inc. (NASDAQ:CONN) shares fell 34.9% to $0.33 in pre-market trading as the company announced plans to close 71 locations across 13 states.
    • Verastem, Inc. (NASDAQ:VSTM) shares fell 27.6% to $2.60 in pre-market trading after the company reported pricing of $55.0 million public offering of common stock, warrants and pre-funded warrants.
    • ATI Physical Therapy, Inc. (NYSE:ATIP) shares declined 25.7% to $4.55 in pre-market trading after gaining around 5% on Tuesday.
    • Volato Group, Inc. (NYSE:SOAR) shares fell 25.2% to $0.4408 in pre-market trading after gaining around 23% on Tuesday.
    • Chijet Motor Company, Inc. (NASDAQ:CJET) fell 21.1% to $4.01 in pre-market trading after jumping 55% on Tuesday.
    • AtlasClear Holdings, Inc. (NASDAQ:ATCH) shares declined 20.6% to $0.44 in pre-market trading after gaining 11% on Tuesday.
    • Wheels Up Experience Inc. (NYSE:UP) fell 9.8% to $3.00 in pre-market trading. Wheels Up Experience will release its second quarter financial results on Thursday, Aug. 8.
    • SFL Corporation Ltd. (NYSE:SFL) shares dipped 9.3% to $12.65 in pre-market trading after the company announced an offering of 8 million common shares.
    • Tesla, Inc. (NASDAQ:TSLA) shares fell 7.2% to $228.56 in pre-market trading. Tesla reported weaker-than-expected earnings for its second quarter, while sales topped estimates. The company reported second-quarter deliveries of 443,956 vehicles and production of 410,831 vehicles, down 5% and 14% year-over-year, respectively.

    Now Read This:

    • Tesla, AT&T And 3 Stocks To Watch Heading Into Wednesday
    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $ATCH
    $ATIP
    $AZTR

    CompanyDatePrice TargetRatingAnalyst
    Verastem Inc.
    $VSTM
    3/12/2026$19.00Buy
    BTIG Research
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Verastem Inc.
    $VSTM
    2/4/2026$18.00Buy
    H.C. Wainwright
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    SEC Filings

    View All

    SEC Form 6-K filed by SFL Corporation Ltd

    6-K - SFL Corp Ltd. (0001289877) (Filer)

    3/18/26 4:31:20 PM ET
    $SFL
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B5 filed by SFL Corporation Ltd

    424B5 - SFL Corp Ltd. (0001289877) (Filer)

    3/17/26 7:33:49 AM ET
    $SFL
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B5 filed by SFL Corporation Ltd

    424B5 - SFL Corp Ltd. (0001289877) (Filer)

    3/17/26 6:56:05 AM ET
    $SFL
    Marine Transportation
    Consumer Discretionary

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gottschalk Max bought $7,260 worth of shares (29,050 units at $0.25), increasing direct ownership by 0.52% to 778,772 units (SEC Form 4)

    4 - Perfect Moment Ltd. (0001849221) (Issuer)

    2/27/26 7:09:06 PM ET
    $PMNT
    Apparel
    Consumer Discretionary

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Hjertaker Ole B

    3 - SFL Corp Ltd. (0001289877) (Issuer)

    3/18/26 4:43:16 PM ET
    $SFL
    Marine Transportation
    Consumer Discretionary

    SEC Form 3 filed by new insider Olesen Aksel

    3 - SFL Corp Ltd. (0001289877) (Issuer)

    3/18/26 4:38:18 PM ET
    $SFL
    Marine Transportation
    Consumer Discretionary

    SEC Form 3 filed by Regencell Bioscience Holdings Limited

    3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)

    3/18/26 9:18:02 AM ET
    $RGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026

    Preclinical research with VS-7375 in combination with PRMT5 inhibitors demonstrated strong durable tumor regressions in KRAS G12D pancreatic cancer models In preclinical pancreatic, lung, and colorectal cancer models, VS-7375 (dual ON/OFF inhibitor) showed deeper and more sustained tumor regression compared to ON-only G12D or pan-RAS inhibitors Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple abstracts have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held April 17-22, 2026, in San Diego, CA. "Preclin

    3/17/26 6:03:00 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancers

    Plenary oral presentation features long-term follow-up data from the Phase 2 RAMP 201 recurrent low-grade serous ovarian cancer clinical trial Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will present new long-term AVMAPKI™ FAKZYNJA™ combination therapy (avutometinib capsules; defactinib tablets) data from the Phase 2 RAMP 201 clinical trial at the Society of Gynecologic Oncology (SGO) 2026 Annual Meeting on Women's Cancers. Additional abstracts accepted for presentation will also be shared at the meeting being held on April 10-13, 2026, in San Juan, Puerto Rico. "W

    3/17/26 4:44:00 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research resumed coverage on Verastem with a new price target

    BTIG Research resumed coverage of Verastem with a rating of Buy and set a new price target of $19.00

    3/12/26 8:55:19 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Leadership Updates

    Live Leadership Updates

    View All

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    AtlasClear Holdings Provides Year-End Corporate Update and Outlines Strategic Priorities for 2026

    TAMPA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE:ATCH) ("AtlasClear" or the "Company"), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking, today reported on fiscal 2025 balance sheet transformation, improved operating momentum, and strategic priorities for 2026. Fiscal 2025: Rebuilding the Foundation and Restoring Financial Flexibility Fiscal 2025 represented a pivotal year for AtlasClear, marked by a comprehensive effort to stabilize the Company's financial position, resolve legacy structural constraints, and reposition the platform for sustainable, scalable growth. As reported in our Quarterly Report f

    1/27/26 8:30:00 AM ET
    $ATCH
    Finance: Consumer Services
    Finance

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Financials

    Live finance-specific insights

    View All

    Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

    Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results and business updates on Wednesday, March 4, 2026, at 4:30 pm ET. To access the conference call, please dial (888) 596-4144 (U.S.) or (646) 968-2525 (international) and enter the passcode 7321921 at least 10 minutes prior to the event start time. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's websit

    2/18/26 7:30:00 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AtlasClear Holdings Reports 84% Revenue Growth, Profitability, and Positive Stockholders' Equity for Fiscal Second Quarter 2026

    -Revenue Increased 84% Year Over Year, Reflecting Accelerating Operating Momentum- -Stockholders' Equity Turned Positive to $21.7 Million, Representing an Increase of ~$60 Million Compared to Fiscal Year-End 2024- -Liquidity Strengthened With $46.2 Million in Cash and Restricted Cash, Enhancing Financial Flexibility- -Wilson-Davis Net Capital Exceeded Regulatory Requirements by $14.4 Million, Underscoring Platform Strength- -Earnings Call Scheduled for Friday, February 13, 2026, at 8:30 AM ET- TAMPA, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE:ATCH) ("AtlasClear" or the "Company"), a technology-enabled financial services platform modernizing tradi

    2/13/26 7:05:00 AM ET
    $ATCH
    Finance: Consumer Services
    Finance

    Perfect Moment Reports Fiscal Q3 2026 Results

    Profitability achieved with third consecutive quarter of gross margin and EBITDA improvement Perfect Moment Ltd. (NYSE:PMNT) ("Perfect Moment" or the "Company"), the high-performance, luxury lifestyle brand that fuses technical excellence with fashion-led designs, reported results for its fiscal third quarter 2026 ended December 31, 2025. Fiscal Q3 2026 Financial Highlights Revenue was consistent with Q3 FY25 at approximately $11.7 million. Gross margin improved to 64.4%, up from 54.8% in Q3 FY25. Total operating expenses decreased 9.9% to $6.9 million compared to $7.7 million in Q3 FY25. Income from operations improved by approximately $1.9 million to $583,000 compared to a

    2/12/26 6:45:00 AM ET
    $PMNT
    Apparel
    Consumer Discretionary

    $ALLR
    $ATCH
    $ATIP
    $AZTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/2/24 4:57:34 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care